Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
3,501–3,520 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
QLEPQuantum Leap Acquisition Corp$298.9M————$1.26M—AI pending
CVCapsoVision, Inc$298.28M—$13.55M+15.3%-$25.32M$9.08M$687KAI pending
ALCOAlico, Inc.$298.15M191.7×$44.07M-5.5%-$147.33M$55.58M$82.92MAI pending
OBIOOrchestra BioMed Holdings, Inc.$297.22M—$33.48M+1,169.2%-$52.7M$20.47M$1.33MAI pending
NNBRNn Inc$296.05M—$422.21M-9.1%-$34M$16.45M$214.8MAI pending
BCYCBicycle Therapeutics PLC$296.01M—$72.59M+105.8%-$218.96M$510.05M$15.21MAI pending
GPACGeneral Purpose Acquisition Corp.$295.86M80.5×———$937.89K—AI pending
KWYKINGSWAY Corp$295.67M—$135M+23.4%-$10.25M$7.37M$51.35MAI pending
SVAQSilicon Valley Acquisition Corp.$294.97M119.8×———$1.18M—AI pending
HCACHall Chadwick Acquisition Corp$294.89M————$30.22K—AI pending
IRHOIron Horse Acquisition II Corp.$294.67M115.9×———$46.83K—AI pending
PACHPioneer Acquisition I Corp$293.5M36.9×———$468.67K—AI pending
OVLYOak Valley Bancorp$293.44M12.4×$81.73M+6.7%$23.91M$194.8M$7.62MAI pending
NHICNewHold Investment Corp. III$293.25M————$364K—AI pending
BACCBlue Acquisition Corp$293.04M66.6×———$201.86K—AI pending
FATEFate Therapeutics Inc$292.96M—$6.65M-51.2%-$136.32M$32.43M$75.68MAI pending
MTNECH4 Natural Solutions Corp$292.68M————$0—AI pending
FULCFulcrum Therapeutics, Inc.$291.84M—$0-100.0%-$74.88M$48.47M$5.28MAI pending
RCMTRcm Technologies, Inc.$291.83M17.8×$319.4M+14.7%$16.33M$6.59M$5.84MAI pending
MTRXMatrix Service Co$291.75M—$873.63M+13.6%-$2.58M$222.97M$19.46MAI pending